- Home
- INDP vs BNZI Comparison
INDP vs BNZI Comparison
Compare INDP & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- BNZI
- Stock Information
- Founded
- INDP 2000
- BNZI 2016
- Country
- INDP United States
- BNZI United States
- Employees
- INDP N/A
- BNZI N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- INDP Health Care
- BNZI
- Exchange
- INDP Nasdaq
- BNZI Nasdaq
- Market Cap
- INDP 8.8M
- BNZI 8.9M
- IPO Year
- INDP N/A
- BNZI N/A
- Fundamental
- Price
- INDP $0.59
- BNZI $1.16
- Analyst Decision
- INDP Strong Buy
- BNZI Strong Buy
- Analyst Count
- INDP 2
- BNZI 1
- Target Price
- INDP $8.50
- BNZI $125.00
- AVG Volume (30 Days)
- INDP 1.2M
- BNZI 1.4M
- Earning Date
- INDP 03-13-2025
- BNZI 05-14-2025
- Dividend Yield
- INDP N/A
- BNZI N/A
- EPS Growth
- INDP N/A
- BNZI N/A
- EPS
- INDP N/A
- BNZI N/A
- Revenue
- INDP N/A
- BNZI $4,310,782.00
- Revenue This Year
- INDP N/A
- BNZI $8.48
- Revenue Next Year
- INDP N/A
- BNZI $166.15
- P/E Ratio
- INDP N/A
- BNZI N/A
- Revenue Growth
- INDP N/A
- BNZI N/A
- 52 Week Low
- INDP $0.58
- BNZI $0.74
- 52 Week High
- INDP $3.10
- BNZI $30.55
- Technical
- Relative Strength Index (RSI)
- INDP 30.03
- BNZI 48.88
- Support Level
- INDP $0.58
- BNZI $1.00
- Resistance Level
- INDP $0.78
- BNZI $1.51
- Average True Range (ATR)
- INDP 0.14
- BNZI 0.20
- MACD
- INDP -0.02
- BNZI 0.03
- Stochastic Oscillator
- INDP 0.89
- BNZI 58.70
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.